[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
[Transactions from January 17, 2017 to February 22, 2017* Trade Date Amount of Shares Purchased Weighted Average Price/Price Per Share ($) Range of Price ($) 1/17/2017 18,589 0.7784 0.7502-0.7980 1/18/2017 18,509 0.7776 0.75505-0.7960 1/19/2017 16,530 0.7645 0.7599-0.7980 1/20/2017 18,589 0.7766 0.77]
[Transactions from January 17, 2017 to February 22, 2017* Trade Date Amount of Shares Purchased Weighted Average Price/Price Per Share ($) Range of Price ($) 1/17/2017 18,589 0.7784 0.7502-0.7980 1/18/2017 18,509 0.7776 0.75505-0.7960 1/19/2017 16,530 0.7645 0.7599-0.7980 1/20/2017 18,589 0.7766 0.77]
[www.umc.com Description 99.1 Announcement on 2017/02/16: Represent subsidiary United Semiconductor (Xiamen) Co., Ltd.to announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2017/02/22: To represent subsidiary Fortune Venture Capital Corp. announce the merger with]
[Contact: Linda Chien Investor Relations 51job, Inc. +86-21-6879-6250 ir@51job.com 51job, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results SHANGHAI, February 22, 2017 51job, Inc. (Nasdaq: JOBS) Fourth Quarter 2016 Financial Highlights: · Total revenues increased 13.6% over Q4 2015 t]
[Ctrip Reports Unaudited Fourth Quarter and Full Year 2016 Financial Results Shanghai, China, February 22, 2017 - Ctrip.com International, Ltd. (Nasdaq: CTRP), a leading travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management in C]
[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
[Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data ]
[Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data ]
[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 23, 2017 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat ]
